Delivery Order SPE2DB22D3016-SPE2DB25FBFV4
Award Date 8/21/25
Potential Completion Date 8/22/25
Potential Value $1.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Remifentanil 2 mg vials under a firm fixed-price contract. The award, issued on August 11, 2025, carries a ceiling value of $7,572.90 with an ultimate completion date of August 12, 2025. This delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Remifentanil is a potent synthetic opioid...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Remifentanil 2 mg vials under a firm fixed-price contract. This award, issued on August 28, 2025, carries a ceiling value of $10,266.97 and is expected to reach ultimate completion on August 29, 2025. The contract is a non-set-aside, competitively awarded delivery order that leverages AmerisourceBergen's broader relationship with DLA to fulfill critical pharmaceutical needs. Performance will be...
- The Defense Logistics Agency awarded a delivery order valued at $11,983.47 to AmerisourceBergen Drug Corp for the supply of Remifentanil 2 mg vials, a potent opioid analgesic commonly used in clinical and surgical settings. This firm fixed-price delivery order, awarded on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The performance...
- The Defense Logistics Agency awarded a delivery order valued at $2,925.36 to AmerisourceBergen Drug Corp for the supply of Remifentanil 2 mg vials. This contract type represents a firm fixed price delivery order with an ultimate completion date of September 18, 2025, and was competitively awarded with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,941.00 to AmerisourceBergen Drug Corp for the supply of Remifentanil 2 mg vials. This firm fixed-price contract, issued on June 6, 2025, with an ultimate completion date of June 9, 2025, represents a competitive award with no set-aside designation. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. Remifentanil is a potent synthetic...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,193.89 to AmerisourceBergen Drug Corp for the supply of Remifentanil 2 mg vials, with an ultimate completion date of September 3, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Remifentanil is a potent synthetic opioid analgesic commonly used in medical and surgical...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Remifentanil 2 mg vials, with a contract ceiling value of $9,762.12. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 12, 2025, and performance location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier supporting federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,459.27 to AmerisourceBergen Drug Corp for the supply of Remifentanil 2 mg vials. The contract utilizes a firm fixed price model with no set-aside designation, indicating competitive award based on open competition. Performance is scheduled to conclude by September 24, 2025, with the point of performance located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $3,635.77 to AmerisourceBergen Drug Corp for the supply of Remifentanil 1 mg vials. This contract, issued on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a firm fixed-price delivery order with no set-aside designation. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,522.64 to AmerisourceBergen Drug Corp for the supply of Remifentanil 2 mg vials. This is a firm fixed price delivery order, effective through August 25, 2025, and represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Remifentanil is a potent synthetic opioid analgesic commonly used in...